Skip to Content
Home | news | Press Releases

Press Releases

Carter, Warnock urge HHS to house health research agency in Georgia

WASHINGTON, D.C. – The entire Georgia Congressional delegation, led by Rep. Earl L. “Buddy” Carter (R-GA) and Senator Raphael Warnock (D-GA), sent a letter to Health and Human Services (HHS) Secretary Xavier Becerra urging him to house the Advanced Research Projects Agency for Health (ARPA-H) headquarters in Georgia.


In the
letter, which was also sent to the White House and Acting Director of ARPA-H, the Members cite Georgia’s “world-class talent, dynamic commercial technology sector, and rich public health research legacy” as justification for this strategic move.


“Georgia is a global leader on medical research and innovation, making it the perfect hub for the newly established ARPA-H. From preeminent universities to top-ranked health systems, Georgia will amplify the agency’s work by positioning it near both a public health mind trust and the people who stand to benefit most from its work,” said Carter. “I would like to thank Senator Warnock, and the rest of the Georgia delegation, for joining the fight to bring ARPA-H to Georgia, and I urge the Biden Administration to do the same.” 


“Georgia’s skilled workforce and public health infrastructure would make it a perfect home for the newly established Advanced Research Projects Agency for Health (ARPA-H),” said Senator Reverend Warnock. “Our state has a strong economy and several cutting-edge public health research institutions, uniquely positioning Georgia to support the nation’s first federal agency dedicated to improving our nation’s ability to speed biomedical and health research. I was proud to lead the entire Georgia congressional delegation in pushing the Biden Administration to house ARPA-H in our great state.”


Read the full letter to Secretary Becerra here.


BACKGROUND: ARPA-H is a newly established agency within the National Institute of Health that, according to their website, will “improve the U.S. government’s ability to speed biomedical and health research.”


###